Walt Whitley, OD, MBA, FAAO, & Selina McGee, OD, FAAO The journey of the dry eye patient can be challenging. They often go to multiple practitioners and try several at-home remedies in an attempt to have their condition taken seriously and get some relief. In this podcast, Selina McGee, OD, FAAO, joins Walt Whitley, OD, MBA, FAAO to discuss the importance of building trust to empower dry eye patients in order to confidently take back control of their condition, as well as how EYSUVIS™ (loteprednol etabonate ophthalmic suspension) 0.25%*—the first FDA-approved steroid for the short-term treatment (up to two weeks) of the signs and symptoms of DED—and its AMPPLIFY® technology may benefit their patients.